
Andrew J. Wang
Examiner (ID: 5764)
| Most Active Art Unit | 1635 |
| Art Unit(s) | 1621, 1639, 1635, 1809, 2628 |
| Total Applications | 378 |
| Issued Applications | 235 |
| Pending Applications | 93 |
| Abandoned Applications | 50 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 4406943
[patent_doc_number] => 06265167
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Targeted RNA degradation using nuclear ribozyme RNA'
[patent_app_type] => 1
[patent_app_number] => 9/314083
[patent_app_country] => US
[patent_app_date] => 1999-05-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 6
[patent_no_of_words] => 4065
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 72
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265167.pdf
[firstpage_image] =>[orig_patent_app_number] => 314083
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/314083 | Targeted RNA degradation using nuclear ribozyme RNA | May 17, 1999 | Issued |
Array
(
[id] => 4102629
[patent_doc_number] => 06066717
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-05-23
[patent_title] => 'RsbW-1 protein'
[patent_app_type] => 1
[patent_app_number] => 9/310488
[patent_app_country] => US
[patent_app_date] => 1999-05-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 15029
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/066/06066717.pdf
[firstpage_image] =>[orig_patent_app_number] => 310488
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/310488 | RsbW-1 protein | May 11, 1999 | Issued |
Array
(
[id] => 4181435
[patent_doc_number] => 06159694
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Antisense modulation of stat3 expression'
[patent_app_type] => 1
[patent_app_number] => 9/288461
[patent_app_country] => US
[patent_app_date] => 1999-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 24655
[patent_no_of_claims] => 23
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159694.pdf
[firstpage_image] =>[orig_patent_app_number] => 288461
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/288461 | Antisense modulation of stat3 expression | Apr 7, 1999 | Issued |
Array
(
[id] => 3942403
[patent_doc_number] => 05998148
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-07
[patent_title] => 'Antisense modulation of microtubule-associated protein 4 expression'
[patent_app_type] => 1
[patent_app_number] => 9/289368
[patent_app_country] => US
[patent_app_date] => 1999-04-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 28986
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/998/05998148.pdf
[firstpage_image] =>[orig_patent_app_number] => 289368
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/289368 | Antisense modulation of microtubule-associated protein 4 expression | Apr 7, 1999 | Issued |
Array
(
[id] => 4285550
[patent_doc_number] => 06268177
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-31
[patent_title] => 'Isolated nucleic acid encoding nucleotide pyrophosphorylase'
[patent_app_type] => 1
[patent_app_number] => 9/285576
[patent_app_country] => US
[patent_app_date] => 1999-04-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14478
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 34
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/268/06268177.pdf
[firstpage_image] =>[orig_patent_app_number] => 285576
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/285576 | Isolated nucleic acid encoding nucleotide pyrophosphorylase | Apr 1, 1999 | Issued |
Array
(
[id] => 4180545
[patent_doc_number] => 06150111
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Methods and kits for recombining nucleic acids'
[patent_app_type] => 1
[patent_app_number] => 9/270485
[patent_app_country] => US
[patent_app_date] => 1999-03-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 9
[patent_no_of_words] => 7734
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 148
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150111.pdf
[firstpage_image] =>[orig_patent_app_number] => 270485
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/270485 | Methods and kits for recombining nucleic acids | Mar 14, 1999 | Issued |
Array
(
[id] => 4181400
[patent_doc_number] => 06159692
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Method and reagent for inhibiting human immunodeficiency virus replication'
[patent_app_type] => 1
[patent_app_number] => 9/249215
[patent_app_country] => US
[patent_app_date] => 1999-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 20
[patent_figures_cnt] => 29
[patent_no_of_words] => 23987
[patent_no_of_claims] => 27
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 67
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/159/06159692.pdf
[firstpage_image] =>[orig_patent_app_number] => 249215
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/249215 | Method and reagent for inhibiting human immunodeficiency virus replication | Feb 11, 1999 | Issued |
Array
(
[id] => 4129588
[patent_doc_number] => 06121000
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-09-19
[patent_title] => 'Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase'
[patent_app_type] => 1
[patent_app_number] => 9/249730
[patent_app_country] => US
[patent_app_date] => 1999-02-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 23
[patent_figures_cnt] => 23
[patent_no_of_words] => 35467
[patent_no_of_claims] => 11
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/121/06121000.pdf
[firstpage_image] =>[orig_patent_app_number] => 249730
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/249730 | Antitumor antisense sequences directed against R1 and R2 components of ribonucleotide reductase | Feb 10, 1999 | Issued |
| 09/241561 | LOCALIZED OLIGONUCLEOTIDE THERAPY FOR PREVENTING RESTENOSIS | Jan 31, 1999 | Abandoned |
| 09/223796 | NOVEL HYPERTENSION RELATED CALCIUM REGULATED GENE (HCARG) | Dec 30, 1998 | Abandoned |
Array
(
[id] => 1508481
[patent_doc_number] => 06441158
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Oligomers that bind to ku protein'
[patent_app_type] => B1
[patent_app_number] => 09/223139
[patent_app_country] => US
[patent_app_date] => 1998-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 8
[patent_no_of_words] => 17650
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/441/06441158.pdf
[firstpage_image] =>[orig_patent_app_number] => 09223139
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/223139 | Oligomers that bind to ku protein | Dec 29, 1998 | Issued |
| 09/223498 | ACID STABLE END-BLOCKED NUCLEIC ACIDS AND THERAPEUTIC USES THEREOF | Dec 29, 1998 | Abandoned |
Array
(
[id] => 4013281
[patent_doc_number] => 05962646
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-10-05
[patent_title] => 'ATP synthase Fo subunit'
[patent_app_type] => 1
[patent_app_number] => 9/216625
[patent_app_country] => US
[patent_app_date] => 1998-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 18320
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/962/05962646.pdf
[firstpage_image] =>[orig_patent_app_number] => 216625
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/216625 | ATP synthase Fo subunit | Dec 15, 1998 | Issued |
Array
(
[id] => 3926195
[patent_doc_number] => 05945505
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-08-31
[patent_title] => 'Human phospholemman-like protein'
[patent_app_type] => 1
[patent_app_number] => 9/213392
[patent_app_country] => US
[patent_app_date] => 1998-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 16874
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/945/05945505.pdf
[firstpage_image] =>[orig_patent_app_number] => 213392
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/213392 | Human phospholemman-like protein | Dec 14, 1998 | Issued |
Array
(
[id] => 4379167
[patent_doc_number] => 06277572
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-08-21
[patent_title] => 'Human NADH dehydrogenase subunits'
[patent_app_type] => 1
[patent_app_number] => 9/208210
[patent_app_country] => US
[patent_app_date] => 1998-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 5
[patent_no_of_words] => 19153
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/277/06277572.pdf
[firstpage_image] =>[orig_patent_app_number] => 208210
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/208210 | Human NADH dehydrogenase subunits | Dec 8, 1998 | Issued |
Array
(
[id] => 4171027
[patent_doc_number] => 06083705
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-07-04
[patent_title] => 'DNA encoding human .alpha. 1 adrenergic receptors and uses thereof'
[patent_app_type] => 1
[patent_app_number] => 9/206899
[patent_app_country] => US
[patent_app_date] => 1998-12-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 37
[patent_figures_cnt] => 37
[patent_no_of_words] => 36612
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 19
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/083/06083705.pdf
[firstpage_image] =>[orig_patent_app_number] => 206899
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/206899 | DNA encoding human .alpha. 1 adrenergic receptors and uses thereof | Dec 6, 1998 | Issued |
Array
(
[id] => 4088194
[patent_doc_number] => 06025464
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-02-15
[patent_title] => 'Two new WD-40 proteins'
[patent_app_type] => 1
[patent_app_number] => 9/204764
[patent_app_country] => US
[patent_app_date] => 1998-12-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 23498
[patent_no_of_claims] => 4
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/025/06025464.pdf
[firstpage_image] =>[orig_patent_app_number] => 204764
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/204764 | Two new WD-40 proteins | Dec 1, 1998 | Issued |
Array
(
[id] => 3947068
[patent_doc_number] => 05955284
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-09-21
[patent_title] => 'Assay method to detect serpin derived from human hypothalamus'
[patent_app_type] => 1
[patent_app_number] => 9/203237
[patent_app_country] => US
[patent_app_date] => 1998-12-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 13152
[patent_no_of_claims] => 1
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 103
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/955/05955284.pdf
[firstpage_image] =>[orig_patent_app_number] => 203237
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/203237 | Assay method to detect serpin derived from human hypothalamus | Nov 30, 1998 | Issued |
Array
(
[id] => 4062424
[patent_doc_number] => 06007997
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-12-28
[patent_title] => 'Human cysteine protease'
[patent_app_type] => 1
[patent_app_number] => 9/193524
[patent_app_country] => US
[patent_app_date] => 1998-11-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 15178
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 19
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/007/06007997.pdf
[firstpage_image] =>[orig_patent_app_number] => 193524
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/193524 | Human cysteine protease | Nov 16, 1998 | Issued |
Array
(
[id] => 3935045
[patent_doc_number] => 05981192
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-11-09
[patent_title] => 'Method of detecting a nucleic acid encoding a vesicle transport protein'
[patent_app_type] => 1
[patent_app_number] => 9/191279
[patent_app_country] => US
[patent_app_date] => 1998-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 13
[patent_no_of_words] => 22112
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 95
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/981/05981192.pdf
[firstpage_image] =>[orig_patent_app_number] => 191279
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191279 | Method of detecting a nucleic acid encoding a vesicle transport protein | Nov 11, 1998 | Issued |